BNET Industries
- Private
- US
Dow Jones Description
Invitrogen is committed to being the leading provider of novel fluorescent reagents and detection solutions that advance scientific and biomedical research worldwide. Supplying superior Molecular Probes products and services, together with striving for customer and employee satisfaction, will be the driving forces of our organization.
Senior Vice President
Ben BulkleyPeer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
invitrogen corp. and webcast - All News and Analysis
Applied Biosystems to Webcast Presentation at the Piper Jaffray Europe Conference
- 2008-06-23
FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast its presentation at the Piper Jaffray Europe Conference in London on Wednesday, June 25, 2008. The live webcast is scheduled to begin at 9:40 a.m. GMT (4:40 a.m. EDT). Peter Dworkin, Vice President of Investor Relations...
Invitrogen Corporation to Webcast Investor Presentation Monday, March 5, 2007
- 2007-02-20
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced that it will be webcasting senior management presentations made to investors as part of a Healthcare Bus Tour on Monday, March 5, 2007, starting at 8:30 a.m. Pacific Time. Presenters will include Greg Lucier, Invitrogen's Chairman and Chief Executive Officer; David Hoffmeister,...
Invitrogen Announces Second Quarter Earnings Release Date for Thursday, August 3, 2006; Conference Call and Slide Presentation will be Webcast
- 2006-07-11
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced details for its upcoming earnings release, conference call and presentation webcast. The Company will release its second quarter 2006 results on Thursday, August 3, 2006, after the market closes. Following the earnings release, the Company will hold a conference call at 5:00...
Invitrogen Corporation to Webcast Investor Presentation Monday, March 27, 2006
- 2006-03-24
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced that it will be webcasting senior management presentations made to investors as part of a Healthcare Bus Tour on Monday, March 27, 2006 starting at 8:30 a.m. Pacific Time. Presenters will include Greg Lucier, Invitrogen's Chairman and CEO; David Hoffmeister, Invitrogen's Chief...
Invitrogen Sets 4th Quarter and Full Year 2005 Earnings Release Date for Tuesday, February 28, 2006; Conference Call and Slide Presentation Will Be Webcast
- 2006-01-26
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced details for its upcoming earnings release, conference call and slide webcast. The Company will release its fourth quarter and full year 2005 results on Tuesday, February 28, 2006 after the market closes. The Company has recently confirmed its full-year guidance for both...
Invitrogen Sets Third Quarter Earnings Release Date for Thursday, October 27, 2005; Conference Call and Slide Presentation will be Webcast
- 2005-10-14
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq: IVGN) today announced details for its upcoming earnings release, conference call and slide webcast. The Company will release its third quarter 2005 results on Thursday, October 27, 2005 after the market closes. Following the earnings release, the Company will hold a conference call at...
Invitrogen Sets Second Quarter Earnings Release Date for Thursday, July 28, 2005; Conference Call and Slide Presentation Will Be Webcast
- 2005-07-08
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced details for its upcoming earnings release, conference call and slide webcast. The Company will release its second quarter 2005 results on Thursday, July 28, 2005, after the market closes. Following the earnings release, the Company will hold a conference call at 5:00...
Invitrogen Sets First Quarter Earnings Release Date for Thursday, April 28, 2005; Conference Call and Slide Presentation Will Be Webcast
- 2005-04-07
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced details for its upcoming earnings release, conference call and slide webcast. The Company will release its first quarter 2005 results on Thursday, April 28, 2005 after the market closes. Following the earnings release, the Company will hold a conference call at 5:00...
Invitrogen Sets 4th Quarter and Full Year 2004 Earnings Release Date for Thursday, February 17, 2005; Conference Call and Slide Presentation Will Be Webcast
- 2005-02-01
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced details for its upcoming earnings release, conference call and slide webcast. The Company will release its fourth quarter and full year 2004 results on Thursday, February 17, 2005 after the market closes. Following the earnings release, the Company will hold a conference...
Invitrogen Corporation Sets Third Quarter Earnings Release Date; Conference Call and Slide Presentation will be Webcast
- 2004-10-08
CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) today announced details for its upcoming earnings release, conference call and slide webcast. The Company will release its third quarter results on Thursday, October 28, 2004 after the market closes. Following the earnings release, the Company will hold a conference call at 5:00 PM...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Ben Bulkley | Senior Vice President |
| David U'Prichard | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Donald W Grimm | Board Member |
| Raymond V. Dittamore | Board of Directors |
| W. Ann Reynolds PhD | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Invitrogen Corporation | Senior Vice President | Current |
| UCSD-CONNECT | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Care Capital, LLC | Venture Partner | Current |
| Red Abbey, LLC | Senior Advisor and Venture Partner | Current |
| University of Glasgow | Honorary Professor | Current |
| Red Abbey, LLC | Advisor | Current |
| Northwestern University | Associate Professor | Current |
| Glasgow University | Honorary Professor | Current |
| Genematrix, Inc. | Board Director | Current |
| Exsar Corporation | Board Director | Current |
| Guilford Pharmaceuticals, Inc. | Director | Current |
| Invitrogen Corporation | Director | Current |
| Cyclacel Limited | Board of Directors | Current |
| GlaxoSmithKline Plc | President | Former |
| SmithKline Beecham Corporation | President of Research and Development | Former |
| Druid Consulting | President | Former |
| Apax Partners Ltd. | Venture Partner | Former |
| Northwestern University School of Medicine | Associate Professor of Pharmacology and Neurobiology | Former |
| Biotechnology Industry Organization | member | Former |
| GlaxoSmithKline Plc | Chairman of Research and Development | Former |
| SmithKline Beecham Corporation | Chairman of R&D | Former |
| Biotechnology Industry Organization | Board Member | Former |
| University of Kansas | Ph.D. in Pharmacology | Former |
| University of Kansas | MS | Former |
| University of Glasgow | B.Sc. in Pharmacology | Former |
| Organization | Position | Status |
|---|---|---|
| Oligoperfect | Founder, Chairman and President, Strategic Design | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Founder, Chairman and President, Strategic Design | Current |
| Resgen Inc. | Founder, Chairman and President, Strategic Design | Current |
| Emiliem, Inc. | Founder, Chairman and President, Strategic Design | Current |
| Hamilton BioVentures | President | Current |
| Molecular Probes | Founder, Chairman and President, Strategic Design | Current |
| Biolayer Corporation Limited | Founder, Chairman and President, Strategic Design | Current |
| Strategic Design | President | Current |
| IDEXX Laboratories, Inc. | Founder, Chairman and President, Strategic Design | Current |
| Seqanswers | Founder, Chairman and President, Strategic Design | Current |
| Microseq | Founder, Chairman and President, Strategic Design | Current |
| Industry Ventures | Founder, Chairman and President, Strategic Design | Current |
| Olink | Founder, Chairman and President, Strategic Design | Current |
| Ionsource, LLC | Founder, Chairman and President, Strategic Design | Current |
| Bioreliance Corporation | Founder, Chairman and President | Current |
| Aegis Therapeutics, LLC | Executive Chairman | Current |
| Strategic Design | Chairman | Current |
| San Diego Regional Chamber of Commerce | Vice Chair | Current |
| Cellzdirect, Inc. | Board of Directors | Current |
| High Throughput Genomics, Inc. | Board of Directors | Current |
| Hamilton BioVentures | Director | Current |
| Intec Telecommunications | Board Member | Current |
| Invitrogen Corporation | Board Member | Current |
| University of Pittsburgh School of Pharmacy | Board Member | Current |
| Angstrom Pharmaceuticals, Inc. | Board of Directors | Current |
| Multiple Peptide Systems Inc | Board of Directors | Current |
| Scripps Clinic | Board Member | Current |
| Hybritech, Inc. | CEO | Former |
| Dura Pharmaceuticals, Inc. | Chief Executive Officer | Former |
| Biosource International, Inc. | Founder, Chairman and President, Strategic Design | Former |
| Hybritech, Inc. | President | Former |
| Copenhagen Capacity | Managing Director | Former |
| Hybritech, Inc. | Director of West Coast Pharmaceutical Sales | Former |
| Eli Lilly and Company | Director of Pharmaceutical Market Research | Former |
| Eli Lilly and Company | management positions | Former |
| U.S. Army | Officer | Former |
| Xcel Pharmaceuticals, Inc. | Former | |
| Verus Pharmaceuticals | Former | |
| Cadence Pharmaceuticals, Inc. | Former | |
| Hybritech, Inc. | Chairman | Former |
| Hybritech | Chairman | Former |
| Biovail Corporation | Chairman | Former |
| Pharmaceutical Market Research | Director | Former |
| Roundtable Inc. | Board of Directors | Former |
| Bioreliance Corporation | Director | Former |
| Somaxon Pharmaceuticals, Inc. | Board of Directors | Former |
| California Healthcare Institute, Inc. | Board of Directors | Former |
| University of Pittsburgh | M.B.A. | Former |
| Pittsburgh Tissue Engineering Initiative, Inc | M.B.A. | Former |
| Baldwin-Wallace College | Master's Degree In Business Administration | Former |
| Pittsburgh Tissue Engineering Initiative, Inc | B.S. In Pharmacy | Former |
| University of Pittsburgh | B.S. In Pharmacy | Former |
Raymond V. Dittamore has served as a Director of the Company since December 2002. Mr. Dittamore is a retired audit partner of Ernst & Young LLP, an international accounting firm. Mr. Dittamore retired in 2001 after 35 years of service with that firm, including 14 years as the managing partner of the firms San Diego office. Mr. Dittamore is also a director of Invitrogen Corporation, Gen-Probe Incorporated, and Digirad Corporation. Mr. Dittamore received a B.S. degree from San Diego State University.
| Organization | Position | Status |
|---|---|---|
| QUALCOMM Incorporated | Board of Directors | Current |
| Molecular Probes | Director | Current |
| Invitrogen Corporation | Board of Directors | Current |
| IDEXX Laboratories, Inc. | Board of Directors | Current |
| Biolayer Corporation Limited | Director | Current |
| Ionsource, LLC | Board of Directors | Current |
| Microseq | Board of Directors | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Board of Directors | Current |
| Industry Ventures | Board of Directors | Current |
| Gen-Probe Inc. | Board of Directors | Current |
| Applied Molecular Evolution, Inc. | Director | Current |
| Ernst & Young | partner | Former |
| Ernst & Young | collaborative editor | Former |
| Digirad Corporation | Board of Directors | Former |
| San Diego State University | B.S. | Former |
| QUALCOMM Incorporated | member | Former |
W. Ann Reynolds, 71, formerly President and Professor of Biology at The University of Alabama at Birmingham, located in Birmingham, Alabama, until 2002. Director since 2006; formerly a Director of OCD since 1993. A graduate of Kansas State Teachers College and the University of Iowa, where she earned a Ph.D. degree, Dr. Reynolds previously served as Chancellor of the City University of New York and as Chancellor of the California State University System. In prior years, she was Provost of the Ohio State University and Professor of Anatomy and Vice Chancellor for Research at the University of Illinois at the Medical Center. Dr. Reynolds is a director of Humana, Inc., Abbott Laboratories, Invitrogen Corporation, and the News-Gazette, Champaign, Illinois.
| Organization | Position | Status |
|---|---|---|
| News Gazette Inc. | Director | Current |
| Humana Inc. | Board of Directors | Current |
| Abbott Laboratories | Board of Directors | Current |
| Owens Corning | Board of Directors | Current |
| Industry Ventures | Board of Directors | Current |
| Business-Higher Education Forum | Member of The Board of The Champaign, Urbana News Gazette | Current |
| Olink | Board of Directors | Current |
| KMG America Corporation | Member of The Board of The Champaign, Urbana News Gazette | Current |
| IDEXX Laboratories, Inc. | Board of Directors | Current |
| Resgen Inc. | Board of Directors | Current |
| Maytag Corporation | Board of Directors | Current |
| Ionsource, LLC | Board of Directors | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Board of Directors | Current |
| Microseq | Board of Directors | Current |
| Abms Member | Board of Directors | Current |
| Invitrogen Corporation | Board of Directors | Current |
| The University of Alabama at Birmingham | President | Former |
| University of Illinois | Professor | Former |
| University of Illinois College of Medicine | Research Professor | Former |
| Emporia State University | M.S. | Former |
| Emporia State University | Bachelors Degree In Biology | Former |
Industry Transcripts by Seeking Alpha
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
Presented by American Express